Additionally, IBD therapy itself may predispose patients to liver injury; sulfasalazine, glucocorticoids, methotrexate, and anti-TNF therapies may result in drug-induced liver toxicity while immunosuppressants commonly prescribed for IBD may make children more susceptible to viral hepatitis [80]. This evidence concerns the gene TNF and inflammatory bowel disease.